Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1998 Jun;85(6):638-46.
doi: 10.1016/s1079-2104(98)90029-4.

Platelet-rich plasma: Growth factor enhancement for bone grafts

Affiliations
Free article
Clinical Trial

Platelet-rich plasma: Growth factor enhancement for bone grafts

R E Marx et al. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998 Jun.
Free article

Abstract

Platelet-rich plasma is an autologous source of platelet-derived growth factor and transforming growth factor beta that is obtained by sequestering and concentrating platelets by gradient density centrifugation. This technique produced a concentration of human platelets of 338% and identified platelet-derived growth factor and transforming growth factor beta within them. Monoclonal antibody assessment of cancellous cellular marrow grafts demonstrated cells that were capable of responding to the growth factors by bearing cell membrane receptors. The additional amounts of these growth factors obtained by adding platelet-rich plasma to grafts evidenced a radiographic maturation rate 1.62 to 2.16 times that of grafts without platelet-rich plasma. As assessed by histomorphometry, there was also a greater bone density in grafts in which platelet-rich plasma was added (74.0% +/- 11%) than in grafts in which platelet-rich plasma was not added (55.1% +/- 8%; p = 0.005).

PubMed Disclaimer

Similar articles

Cited by

Publication types

MeSH terms

Substances